Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis

Abstract Background Checkpoint inhibitor pneumonitis (CIP) that develops following immune checkpoint inhibitor (ICI) treatment can be difficult to distinguish from other common etiologies of lung inflammation in cancer patients. Here, we evaluate the bronchoalveolar lavage fluid (BAL) for potential...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Michelle Ploch, Songzhu Zhao, Lai Wei, Joshua A. Englert, Sarah P. Cohen, Morgan A. Inks, Alexa S. Meara, Lynn A. Fussner, Dwight H. Owen, Kevin Ho
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Springer 2025-01-01
Reeks:	Cancer Immunology, Immunotherapy
Onderwerpen:	Immune checkpoint inhibitor pneumonitis cancer immunotherapy
Online toegang:	https://doi.org/10.1007/s00262-024-03902-3
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!